XL-protein and Antlia Bioscience Announce Collaboration to Develop Long-acting Peptide Therapy of Chronic Heart Failure using PASylation® Technology Kumar Jeetendra | October 22, 2020 SAN DIEGO, U.S.A., and FREISING, Germany, October 15, 2020 – Life Science Newswire – Antlia Bioscience, Inc., a privately owned biopharmaceutical company located in San Diego, California, and XL-protein GmbH, a privately owned biopharmaceutical company located in Germany, are pleased to announce a strategic slliance using XL-protein’s proprietary PASylation® technology for plasma half-life extension to …
Lupin, Concord Biotech get USFDA gesture for generic immunosuppressant cases Kumar Jeetendra | November 12, 2020 New Delhi, Nov 12 (PTI) Drug firm Lupin on Thursday stated that in alliance with Concord Biotech, it has obtained acceptance from the US health regulator to market generic immunosuppressant Tacrolimus capsules used in the Western industry. In cooperation with Concord Biotech, the business has obtained approval from the United States Food and Drug Administration …
Unilever says its mouthwash will decrease 99.9% Covid in the wake of flushing Kumar Jeetendra | November 21, 2020 International FMCG major Unilever on November 21 said it will bring to India its mouthwash formulation, which, it claims, will reduce 99.9 percent of coronavirus after 30 minutes of rinsing. “Unilever has confirmed that preliminary lab test results reveal that mouthwash formulation containing CPC Technology reduces 99.9 percent of SARS-CoV-2, the virus which causes COVID-19, …
Alembic Pharma gets USFDA endorsement for Metolazone tablets Kumar Jeetendra | December 3, 2020 New Delhi, Dec 3 (PTI) Drug firm Alembic Pharmaceuticals on Thursday said it has received approval from the US health regulator for Metolazone tablets, indicated for the treatment of salt and water retention caused by heart failure or kidney disease. The approved product is therapeutically equivalent to the reference listed drug product Zaroxolyn Tablets 2.5 …
Rhizen Pharma gets USFDA endorsement for stage one clinical preliminaries for Covid-19 drug Kumar Jeetendra | December 3, 2020 New Delhi, Dec 2 (PTI) Rhizen Pharmaceuticals, a member firm of Alembic Pharmaceuticals, on Wednesday said it has received approval from the US health regulator to commence phase one clinical trials on retroviral oral drug for the treatment of COVID-19. The Switzerland-based firm, which will be a clinical-stage oncology-focussed biopharmaceutical company, has obtained approval for …
Sinovac Biotech has secured $515 million in financing from a local company to double manufacturing capacity of its corona vaccine Kumar Jeetendra | December 7, 2020 China’s Sinovac Biotech has secured $515 million in financing from a local company to double manufacturing capacity of its coronavirus vaccine, the companies said on Monday, as it anticipates efficacy data of its experimental shot this month. The investment deal also comes as Sinovac expands provide deals and trials of its experimental COVID-19 vaccine CoronaVac …
Cipla Launches ‘CIPtest’ Rapid Antigen Detection Test for COVID-19 Diagnosis Kumar Jeetendra | December 16, 2020 Mumbai, India; December 16, 2020: Cipla Limited (BSE: 500087; NSE: CIPLA EQ) referred to as “Cipla” today announced its partnership with the Premier Medical Corporation Private Limited for commercialisation of the rapid antigen test kits for COVID-19 in India. The company will commence supply from this week. This is Cipla’s second launch in the diagnostics …
... Kumar Jeetendra | January 2, 2021 New Delhi: Drug important Glenmark Pharma on Thursday said it has received final approval from the US health regulator for Tadalafil tablets, used to treat erectile dysfunction and enlarged prostate. The business also received two tentative approvals in the US health regulator. Glenmark Pharmaceuticals Ltd has received final approval from the United States Food and …
Strides Pharma Science arm gets USFDA gesture for HIV treatment drug Kumar Jeetendra | January 15, 2021 Drug firm Strides Pharma Science on Friday said its step-down wholly-owned subsidiary, Strides Pharma Global, has obtained approval from the US health regulator for Emtricitabine and Tenofovir Disoproxil Fumarate pills, used to treat HIV. The approved product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Truvada tablets of Gilead Sciences. Strides Pharma …
WHO says close to Pfizer deal that would give poorer nations access Kumar Jeetendra | January 19, 2021 The World Health Organization is in advanced negotiations with Pfizer to include the company’s COVID-19 shot in the body’s vaccine-sharing strategy, which would speed vaccine deliveries to poorer countries, a senior WHO official said on Monday. The COVAX scheme — headed by the WHO and GAVI vaccine alliance — is due to begin rolling out …
Industry looks for interest in COVID-19 immunization program: CII Kumar Jeetendra | February 18, 2021 Indian industry has sought involvement from the continuing COVID-19 vaccination programme in order to help the government reach its identified target priority groups quicker, which is crucial for getting the workforce back to work and the economy back on track, the Confederation of Indian Industry (CII) said on Thursday. To action the successful roll out …
Cipla Therapeutics and SIGA Technologies Announce Strategic Partnership to support innovation and provide access to novel antibacterial drugs against biothreats Kumar Jeetendra | March 23, 2021 March 23, 2021, MUMBAI – Cipla Therapeutics, an affiliate of Cipla Limited (BSE: 500087; NSE: CIPLA EQ; referred to as “Cipla”) and SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market announced entering into a strategic partnership to deliver sustained innovation and access to novel antibacterial drugs, particularly …
